P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0429-2
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2019
Authors
Publisher
Springer Science and Business Media LLC